Summary by Moomoo AI
On July 17, 2024, Three Leaves Bio-Pharmaceutical Co., Ltd. (Three Leaves Bio-B) resubmitted the monthly shareholding report as of June 30, 2024. The report shows that the company's legal/registered share capital remains at 2,000,000,000 shares, with a par value of $0.0001 per share, and a total of $200,000. The number of issued shares (excluding treasury shares) increased from 1,297,047,429 shares at the end of last month to 1,297,048,929 shares, an increase of 1,500 shares. These additional shares were obtained through exercising share options. The company's pre-listing share option plan was approved by the shareholders' meeting on April 15, 2021, and the post-listing share option plan was passed on September 26, 2021. The report did not mention any information about Hong Kong depositary receipts and confirmed that all securities issued comply with relevant listing rules and legal requirements.